JPRN-UMIN000029630已完成未知
Randomized crossover multi-facility joint comparative test to evaluate the effect on type 1 diabetic patient's blood glucose fluctuation due to difference in long-acting insulin (Insulin Degludec vs Insulin Glargine U300) - Randomized crossover multi-facility joint comparative test to evaluate the effect on type 1 diabetic patient's blood glucose fluctuation due to difference in long-acting insulin (Insulin Degludec vs Insulin Glargine U300)
Division of Diabetes and Endocrinology Department of Internal Medicine,Kobe University Graduate School of Medicine0 个研究点目标入组 46 人开始时间: 2017年10月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 46
研究概览
简要总结
Comparing the SD of FBG level, IDeg was noninferior to IGla-300 in SD of FBG.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 99years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)HbA1c > 9.0% 2)other medication to affect glucose concentarion 3)severe hypertension(Systolic blood pressure of 180 mmHg or more, diastolic blood pressure of 100 mmHg or more) 4)severe liver dysfunction (Increase of AST, ALT more than 2.5 times normal upper limit) 5)severe renal dysfunction (Cr > 2) 6)severe heart failure (NYHA>2) 7)Recent serious hypoglycemia, recent hospitalization due to ketoacidosis 8)retinopathy with high bleeding risk 9)pregnant or breast-feeding women 10)Cancer patient 11)psychological disorder 12) others inappropriate for this study
研究者
相似试验
已完成
3 期
Effects of Insulin Degludec and Insulin Glargine U300 on glucose variability in Individuals with Type 1 Diabetestype 1 diabetesJPRN-jRCTs051180138Sakaguchi Kazuhiko46
已完成
2 期
Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)COVID-19NCT04480424Grifols Therapeutics LLC100
已完成
3 期
Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced NeutropeniaChemotherapy Induced NeutropeniaNCT01674855Dong-A ST Co., Ltd.74
已完成
不适用
International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary LesionsDocumented Silent IschemiaUnstable AnginaStable AnginaNCT01373502CID - Carbostent & Implantable Devices323
已完成
3 期
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG) Compared to Gamunex-C in Participants With Primary Humoral ImmunodeficiencyPrimary ImmunodeficiencyNCT04561115Grifols Therapeutics LLC33